The role of the microbiome in gastrointestinal inflammation. Issue 6 (25th June 2021)

• Record Type: Journal Article
• Authors: Sanders, David J.; Inniss, Saskia; Sebepos-Rogers, Gregory; Rahman, Farooq Z.; Smith, Andrew M.
• Is Part Of: Bioscience reports. Volume 41:Issue 6(2021)
• Publication Date: 2021-06-25
• Subjects: Dysbiosis -- Gastrointestinal physiology -- Homeostasis -- Inflammation -- Microbiome -- Mucosa; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20203850
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract: The microbiome plays an important role in maintaining human health. Despite multiple factors being attributed to the shaping of the human microbiome, extrinsic factors such diet and use of medications including antibiotics appear to dominate. Mucosal surfaces, particularly in the gut, are highly adapted to be able to tolerate a large population of microorganisms whilst still being able to produce a rapid and effective immune response against infection. The intestinal microbiome is not functionally independent from the host mucosa and can, through presentation of microbe-associated molecular patterns (MAMPs) and generation of microbe-derived metabolites, fundamentally influence mucosal barrier integrity and modulate host immunity. In a healthy gut there is an abundance of beneficial bacteria that help to preserve intestinal homoeostasis, promote protective immune responses, and limit excessive inflammation. The importance of the microbiome is further highlighted during dysbiosis where a loss of this finely balanced microbial population can lead to mucosal barrier dysfunction, aberrant immune responses, and chronic inflammation that increases the risk of disease development. Improvements in our understanding of the microbiome are providing opportunities to harness members of a healthy microbiota to help reverse dysbiosis, reduce inflammation, and ultimately prevent disease progression.